The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,085,922,457.04 firm fixed price contract to Glaxosmithkline, LLC for the provision of vaccines for children. The contract, which did not have a set-aside designation, has a performance period ending on March 31, 2018. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of vaccines, antivirals, and other pharmaceutical products to federal agencies including the Departments of Defense, Veterans Affairs, and Health and Human Services. The contract supports the CDC's routine pediatric and adult immunization programs and disease prevention efforts.
Generated 3/22/24, 9:12 PM